Cardiotoxicity of Immune Checkpoint Inhibitors

PURPOSE OF REVIEW: Immune checkpoint inhibitors (ICIs) have improved the survival of several cancers. However, they may cause a wide range of immune-related adverse events (irAEs). While most irAEs are manageable with temporary cessation of ICI and immunosuppression, cardiovascular toxicity can be a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Curr Oncol Rep
Hlavní autoři: Patel, Rushin P., Parikh, Rohan, Gunturu, Krishna S., Tariq, Rana Zouveenoor, Dani, Sourbha S., Ganatra, Sarju, Nohria, Anju
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer US 2021
Témata:
Cardio-oncology (EH Yang, Section Editor)
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8088903/
https://ncbi.nlm.nih.gov/pubmed/33937956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-021-01070-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky